GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Lifted by Prime Capital Investment Advisors LLC

Prime Capital Investment Advisors LLC increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 42.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,866 shares of the company’s stock after buying an additional 1,440 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $376,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of GEHC. Reliant Investment Management LLC grew its stake in GE HealthCare Technologies by 1.6% in the fourth quarter. Reliant Investment Management LLC now owns 55,825 shares of the company’s stock valued at $4,316,000 after purchasing an additional 867 shares in the last quarter. Highlander Capital Management LLC grew its stake in GE HealthCare Technologies by 7.2% in the fourth quarter. Highlander Capital Management LLC now owns 2,997 shares of the company’s stock valued at $232,000 after purchasing an additional 200 shares in the last quarter. International Assets Investment Management LLC grew its stake in GE HealthCare Technologies by 8,158.8% in the fourth quarter. International Assets Investment Management LLC now owns 605,290 shares of the company’s stock valued at $46,801,000 after purchasing an additional 597,961 shares in the last quarter. Leavell Investment Management Inc. grew its stake in GE HealthCare Technologies by 6.2% in the fourth quarter. Leavell Investment Management Inc. now owns 25,819 shares of the company’s stock valued at $1,996,000 after purchasing an additional 1,500 shares in the last quarter. Finally, Camelot Portfolios LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $336,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $86.28 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The stock has a market capitalization of $39.37 billion, a PE ratio of 28.57, a P/E/G ratio of 2.97 and a beta of 0.94. The stock has a 50-day simple moving average of $88.21 and a 200 day simple moving average of $77.22.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.11. The business had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.31 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.97%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 price target for the company. Citigroup upped their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Evercore ISI upped their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Finally, Mizuho upped their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $95.08.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.